Introduction
Invasive candidiasis (IC) is a persistent growing health problem that causes considerable morbidity and mortality. Many factors are associated with the increase including increased use of broad-spectrum antibiotics, invasive procedures, immunosuppression, and an aging population. In addition, Candida blood stream infection (BSI) is the 4th most common nosocomial BSI in the United States which would obviously impact the rise in IC [1] . Candida cerebral abscess is an uncommon infection with little data available regarding diagnosis, management, and outcomes. We describe a case of successfully treated Candida cerebral abscess and review the literature regarding this infection.
Case report
A 57-year-old homeless man with a history of uncontrolled diabetes mellitus type 2 and prior intravenous drug abuse was admitted to our hospital after being found unresponsive. On physical examination, the patient was afebrile with a heart rate of 68 beats per minute and blood pressure of 128/77 mmHg. The patient was cachectic with diffuse folliculitis and skin excoriations. No heart murmur or evidence of oropharyngeal candidiasis was found on physical exam. Neurological examination revealed lethargy and disorientation, an expressive and receptive aphasia, and a bilateral upper extremity resting tremor.
Laboratory studies indicated a white blood cell count of 10.5 mg/dl, hemoglobin of 11.9 mg/dl, glucose of 325 mg/dl, and glycated hemoglobin (HgA1c) of 15.1%. No microorganisms were recovered on two sets of blood cultures using a Becton Dickinson Bactec FX detection system (Franklin Lakes, NJ, USA). Cerebral magnetic resonance imaging (MRI) revealed innumerable small ( Ͻ 1 cm) ring-enhancing lesions within the supratentorial white matter (Figure 1 ) with abundant surrounding vasogenic edema. A chest, abdomen, and pelvis computed tomography (CT) scan with contrast was normal. A transesophageal echocardiogram did not show any evidence of valvular vegetation while a urine drug screen and serum alcohol level were negative. No evidence was noted of human immunodefi ciency virus (HIV) infection through the use of rapid enzyme-linked immunosorbent assay (ELISA).
An empiric regimen of ceftriaxone, vancomycin, and metronidazole was begun for suspected bacterial cerebral abscesses. A lumbar puncture was performed, which revealed an opening pressure of 30 mm Hg, 30 red blood cells/ μ l, 4 white blood cells/ μ l, protein of 102 mg/dl, and glucose of 92 mg/dl. The cerebral spinal fl uid (CSF) crytococcal antigen and India ink tests were negative, as were the Venereal Disease Research Laboratory (VDRL) test, and a CSF toxoplasmosis IgG Ͻ 0.90. No microorganisms were found through gram stain of the CSF or culture.
Two days after admission, the patient became acutely lethargic and a repeat CT scan of the brain revealed increasing edema with mass effect and early evidence of herniation. Intravenous (IV) dexamethasone was administered and the patient underwent a stereotactic biopsy of a lesion in the right frontal lobe to obtain an accurate diagnosis of the cerebral condition. A Grocott Methenamine Silver (GMS) stain of the aspirated material revealed fungal elements, and Candida albicans was obtained in culture. The patient was started on liposomal amphotericin B at 5 mg/kg IV daily and oral fl ucytosine at 25 mg/kg every 6 h. In vitro antifungal susceptibility tests indicated the following MICs: amphotericin B 0.5 mcg/ml, fl uconazole 0.5 mcg/ml and 5-fl ucytosine Յ 0.06 mcg/ml.
Multiple areas of bilateral retinal whitening consistent with chorioretinitis were noted on a dilated ophthalmic exam and as a result the patient was started on oral fl uconazole at 400 mg daily for improved ocular penetration. Since the patient continued to improve neurologically, he was discharged to a subacute rehabilitation facility. The patient was treated with liposomal amphotercin B, fl ucytosine and fl uconazole for 6 weeks with plans to continue the fl uconazole 400 mg orally daily for a 6 -12-month course depending on the patient ' s clinical and radiological response.
The patient was seen in follow-up one month after discharge and noted to be doing well. A repeat brain MRI without IV contrast was performed 5 weeks after discharge and showed a reduction in the extensive edema seen on prior MRI but with persistent enhancing lesions. The patient was subsequently lost to follow-up.
Results
A review of the literature revealed 44 case reports and series which detailed 148 cases (including the present one) of Candida cerebral abscess. Since a large portion (104/148, 70%) of the reports were based on autopsy fi ndings, there were little data regarding patient presentation, treatment, and outcomes, but they did provide information regarding demographics, comorbidities and candidemia. Therefore, we found it useful to divide cases into non-autopsy cases (which contained signifi cantly greater clinical information) (Table 1) , and autopsy cases (Table 2) .
A review of all cases in which the age of the patient was provided revealed the median to be 30 Ϯ 20 years (mean 30, range 0 -87), 33% (20/60) of patients were less than 18 years of age, and 17% (10/60) were less than 1 year old. Seven (70%) of the 10 infant cases ( Ͻ 1 year old), were described as preterm. Of those cases reporting patient gender, 61% were concerned with male subjects (57/94). The comorbidities associated with the development of Candida cerebral abscess included: prior antibiotic use (77/148, 52%), prior surgery (42/148, 28%), malignancy (41/148, 28%), stem cell or solid organ transplant (29/148, 20%), prior corticosteroid use (24/148, 16%), central venous catheter (CVC) insertion (15/148, 10%), and burns (10/148, 7%).
Clinical presentations varied greatly as reported 42/ 148 cases (28%) and included fever (32/42, 76%), altered mental status (23/42, 55%), focal neurological signs (22/42, 52%), seizure (16/42, 38%), headache (9/42, 21%), and meningeal signs (6/42, 14%).
The method by which the diagnosis of Candida cerebral abscess was established was described in 111 cases. Notably, it was most frequently made through the use of tissue biopsy (108/111, 97%) as opposed to cerebrospinal fl uid (CSF) analysis (3/111, 3%). However, as previously indicated, 70% of cases (104/148) were established at autopsy making tissue diagnosis more likely. Lumbar puncture was performed in 15% (22/148) of cases with 77% (17/22) of CSF cultures nondiagnostic for Candida cerebral abscess. Blood cultures were performed in 38% (56/148) of cases of which 55% were positive for Candida (31/56).
Radiologic evaluation, reported in 90 cases, revealed that abscesses tended to be multiple rather than solitary (69/90, 77%).
The most common species recovered and identifi ed was C. albicans , involved in 56% of cases (83/148), with Candida species not reported (59/148, 40%) the next frequent agent, followed by C. parapsilosis (1/148, 1%), C. tropicalis (2/148, 1%) and C. guilliermondi (1/148, 1%). Mixed infection was reported in 10/148 cases (7%) and involved Aspergillus species (3/10), streptococcal species (2/10), Toxoplasma gondii (2/10), Cryptococcus neoformans , Enterobacter species, methicillin-resistant Staphylcoccus aureus , and Cladophialophora bantiana (each 1/10). Only 17% (25/148) of the reports described the use of antifungal treatment, with the most common initial regimens composed of amphotericin B alone (10/25, 40%), amphotericin B and fl uconazole (5/25, 20%), fl uconazole alone (3/25, 12%), amphotericin B and fl ucytosine (2/25, 8%), nystatin (2/25, 8%), amphotericin B, fl ucytosine, and fl uconazole (1/25, 4%), amphotericin B, fl ucytosine, and itraconzole (1/25, 4%), and caspofungin (1/25, 4%). Of the non-autopsy cases, median length of treatment was
Discussion
Candida species are the most common cause of invasive fungal diseases with central nervous system (CNS) infections increasingly prevalent causing of morbidity and mortality, especially in hospitalized patients [1, 3] . Candida cerebral abscess is a rare disease, with only 148 cases, including our patient, reported in the English literature to date. Its diagnosis is diffi cult to establish and a clinician must have a strong clinical suspicion, as less invasive diagnostic methods, such as blood cultures, lumbar puncture, and radiographic studies, are not very productive and yield non-specifi c results. Of note, the presentation can be similar to that of bacterial cerebral abscess and radiographic and laboratory data may not be of assistance in differentiating the two conditions [3] . In this case review series, the majority of diagnoses were confi rmed by brain biopsy (97%) which was relatively easy to establish as a high percentage of cases were from autopsy. However, this fact also indicates how diffi cult it is to make the diagnosis.
Hematogenous spread is likely a frequent source for the development of Candida cerebral abscess, but in the cases reviewed, blood cultures revealed candidemia in only 55% of cases. Lumbar puncture, although performed infrequently, yielded Candida growth in only 23% of cases. Thus, candidemia and abnormal CSF studies may be a clue to the diagnosis, but the diagnosis of candidal cerebral abscess cannot be ruled out in the absence of such results.
Radiographic studies are similarly nonspecifi c with imaging useful to confi rm the diagnosis of cerebral abscess, but it is diffi cult to differentiate bacterial, protozoal, and fungal abscess. Appearance on CT or MR imaging is nonspecifi c, typically appears as areas of hypoattenuation and edema is variable. Intravenous contrast reveals ring enhancement and can aid in the detection of smaller lesions [4, 5] . Cerebral sonography can be used for imaging neonates [6] . In this review, radiographic studies more frequently revealed multiple abscesses rather than a single large abscess.
Treatment outcomes were poor, with an overall mortality rate of 69%, excluding autopsy cases. Surgical excision or drainage was infrequently reported, occurring in only 20% of cases. Surgical drainage was not performed on our patient due to the low numbers of foci of cerebral infection. Following a brain biopsy for diagnosis, our patient underwent 3 months of medical therapy with a good result. The patient was to complete 6 -12 months of therapy based on radiological and clinical improvement, but he was lost to follow-up. Yampolsky et al. reported a similar case of a diabetic patient with Candida cerebral abscess treated successfully with surgical drainage, IV amphotericin B and fl uconazole for one month, followed by 4 months of oral fl uconazole [7] .
The current Infectious Diseases Society of America (IDSA) guidelines recommend treatment of CNS candidiasis with IV amphotericin B with or without 5-fl ucytosine for several weeks, followed by fl uconazole daily. Treatment is recommended until all signs and symptoms, CSF and radiographic abnormalities have resolved [1] . Echinocandins are a poor choice for Candida cerebral abscess as they have suboptimal CNS penetration [8] . Prabhu and Orenstein reported a case of progression to brain abscess during treatment of C. albicans endocarditis with caspofungin [9] .
Successful treatment of Candida cerebral abscess requires an aggressive treatment approach with a prolonged course of antibiotics and hinges on making the diagnosis early. It requires an astute clinician with a high index of suspicion to diagnose Candida cerebral abscess. Blood cultures and CSF studies have variable results and may not be helpful. This diagnosis should be considered in patients with a history of immunosuppression, CVC, or prolonged antibiotic use, particularly in patients with a poor response to antibacterial agents. In neonatal cases, prematurity, a multifactorial immunosuppressive state often associated with prolonged hospitalization, CVC placement, antibiotic treatment, and gastrointestinal pathology is a risk factor [10, 11] . Successful treatment likely requires early diagnosis and long-term antibiotic treatment, with the endpoint determined by radiographic and clinical resolution of the abscess and symptoms.
